Doctors test direct artery delivery of Patient's own stem cells for stubborn bowel disease
NCT ID NCT04312113
Summary
This early-stage study is testing whether a patient's own fat-derived stem cells can be safely delivered directly into the arteries supplying the colon to treat ulcerative colitis. It involves 20 adults with moderate-to-severe disease that hasn't improved with at least two standard medications. The main goal is to check for safety issues, while also looking for early signs of reduced bowel inflammation and healing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.